Stocks Thread

Collapse
X
Collapse
 
  • Page of 4
  • Time
  • Show
Clear All
new posts
Previous 1 2 3 4 template Next
  • Kamal
    replied
    Re: Stocks Thread

    Originally posted by floridaorange
    Doing very well with OCGN - Kamal - what do your pals in India tell you

    https://finance.yahoo.com/news/ocuge...165832224.html
    Just saw this, I haven't heard much of it to be honest. I don't follow much of what is going on back home other than with family and friends.

      Leave a comment:

    • floridaorange
      replied
      Re: Stocks Thread

      Great news India! OCGN!

      The Subject Expert Committee (SEC) of Central Drugs Standards Control Organisation (CDSCO) makes recommendations in respect of Accelerated Approval Process request of M/s Serum Institute of India and M/s Bharat Biotech International Ltd as well as about Phase-III Trials of M/s Cadila Healthcare Ltd
      https://pib.gov.in/PressReleseDetailm.aspx?PRID=1685678
      The Subject Expert Committee of CDSCO met on 1st and 2nd January, 2021 and made the following recomm

        Leave a comment:

      • floridaorange
        replied
        Re: Stocks Thread

        Doing very well with OCGN - Kamal - what do your pals in India tell you

        Is Ocugen Stock Still Worth Buying After Its 800%-Plus Rally? Analyst Weighs In
        https://finance.yahoo.com/news/ocugen-stock-still-worth-buying-165832224.html
        Can you feel the ground moving beneath your feet? Shares of Ocugen (OCGN) skyrocketed over 800% in the past three trading sessions after the biopharmaceutical company disclosed it had signed a binding letter of intent (LOI) with India based Bharat Biotech to co-develop a COVID-19 vaccine for the U.S. market.Bharat's offering COVAXIN, a whole-viron inactivated COVID-19 vaccine candidate, has already shown promise in Phase 1 and 2 clinical trials in India and the enrollment of 26,000 subjects for the Phase 3 study is currently underway.The agreement stipulates Ocugen will hold the vaccine’s U.S. rights, and the remaining details are expected to be finalized over the coming weeks.Considering Bharat’s reputation for world-class R&D and manufacturing capabilities in vaccines and bio-therapeutics, H.C. Wainwright analyst Swayampakula Ramakanth thinks the company is a “suitable partner.”Ramakanth believes the “broad immunity targeting different components of the virus could potentially provide better protection against emerging mutant viruses, such as the one currently circulating in the UK.” With this in mind, in the Phase 1 study, COVAXIN has shown robust antibody responses against spike (S1) protein, receptor-binding domain (RBD) and the nucleocapsid (N) protein of SARS-CoV-2. “More importantly,” the 5-star analyst added, “COVAXIN also induces comparable levels of neutralizing antibodies to those in human convalescent serum," which, the analyst believes," bodes well for the success of the ongoing Phase 3 trial in India.”Over the next few weeks, Ocugen is expected to meet with the FDA to discuss how to advance COVAXIN’s development.However, due to the fact the details of the definitive agreement have yet to be finalized, in addition to the current lack of “insight into the U.S. regulatory pathway or commercial strategy,” Ramakanth stays on the sidelines for now.Accordingly, the analyst rates OCGN a Neutral (i.e. Hold) without suggesting a price target. (To watch Ramakanth’s track record, click here)In contrast, all 3 other analysts who have recently posted an Ocugen review rate the stock a Buy. However, the Strong Buy consensus rating is backed with a $0.9 price target, which implies downside of 68% from current levels. This is most likely a result of the stock’s meteoric rise and analysts’ inability to turnaround new price targets so quickly. (See OCGN stock analysis on TipRanks)To find good ideas for coronavirus stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

          Leave a comment:

        • i!!ustrious
          replied
          Re: Stocks Thread

          cheers bretheren may we sumday have a yacht flotilla ms

            Leave a comment:

          • floridaorange
            replied
            Re: Stocks Thread

            Went in big (for me) on IDEX. Will swing trade it this week and then hopefully move earnings over to VXRT if i can get it sub $8.

              Leave a comment:

            • floridaorange
              replied
              Re: Stocks Thread

              Nice work!!

                Leave a comment:

              • Kamal
                replied
                Re: Stocks Thread

                deleted
                Last edited by Kamal; December 2, 2020, 04:33:22 PM.

                  Leave a comment:

                • REDROCK
                  replied
                  Re: Stocks Thread

                  Shipping stocks have been interesting to me, I haven't pulled the trigger on any of them though. Which ones have been good to you Kamal?

                  Currently mostly invested in DNK - made a good return on NAKD, but my long investment has been VXRT. RH is cool, because it's easy, but Webull has more detailed info.

                    Leave a comment:

                  • Kamal
                    replied
                    Re: Stocks Thread

                    Not a day trader but due to the market crash in Feb this year, I signed up for an account on Robinhood and traded some shipping stocks.

                      Leave a comment:

                    • floridaorange
                      started a topic Stocks Thread

                      Stocks Thread

                      I didn’t know where else to start this thread.

                      Anyone here day trade or long term invest?
                      Tags: None
                      Previous 1 2 3 4 template Next

                      [ms] Statistics

                      Collapse
                      Topics: 191,766   Posts: 1,237,003   Members: 53,129   Active Members: 68
                      Welcome to our newest member, newiron009.
                      Working...

                      We process personal data about users of our site, through the use of cookies and other technologies, to deliver our services, personalize advertising, and to analyze site activity. We may share certain information about our users with our advertising and analytics partners. For additional details, refer to our Privacy Policy.

                      By clicking "I AGREE" below, you agree to our Privacy Policy and our personal data processing and cookie practices as described therein. You also acknowledge that this forum may be hosted outside your country and you consent to the collection, storage, and processing of your data in the country where this forum is hosted.

                      I Agree